anamorelin monohydrochloride, composition, process for preparing anamorelin monohydrochloride, pharmaceutical composition and method for producing a pharmaceutical dosage form

摘要

The present invention relates to particulate forms of anamorelin monohydrochloride or a composition comprising anamorelin monohydrochloride having controlled chloride content, preferably isolated in an amorphous and/or fine particulate state, processes for making the particulate forms, and pharmaceutical compositions comprising the particulate forms.